BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 24780718)

  • 1. The burden of idiopathic pulmonary fibrosis: an unmet public health need.
    Lee AS; Mira-Avendano I; Ryu JH; Daniels CE
    Respir Med; 2014 Jul; 108(7):955-67. PubMed ID: 24780718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burden of illness in idiopathic pulmonary fibrosis.
    Collard HR; Ward AJ; Lanes S; Cortney Hayflinger D; Rosenberg DM; Hunsche E
    J Med Econ; 2012; 15(5):829-35. PubMed ID: 22455577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical impact of major comorbidities on idiopathic pulmonary fibrosis.
    Suzuki A; Kondoh Y
    Respir Investig; 2017 Mar; 55(2):94-103. PubMed ID: 28274539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies to manage costs in idiopathic pulmonary fibrosis.
    Owens GM
    Am J Manag Care; 2017 Jul; 23(11 Suppl):S191-S196. PubMed ID: 28978214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Key Cost Generating Events for Idiopathic Pulmonary Fibrosis: A Systematic Review.
    Vaidya S; Hibbert CL; Kinter E; Boes S
    Lung; 2017 Feb; 195(1):1-8. PubMed ID: 27866277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic pulmonary fibrosis: an Australian perspective.
    Prasad J; Holland AE; Glaspole I; Westall G
    Intern Med J; 2016 Jun; 46(6):663-8. PubMed ID: 27257148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthcare resource utilization among patients diagnosed with idiopathic pulmonary fibrosis in the United States.
    Wu N; Yu YF; Chuang CC; Wang R; Benjamin NN; Coultas DB
    J Med Econ; 2015 Apr; 18(4):249-57. PubMed ID: 25428658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review.
    Raghu G; Amatto VC; Behr J; Stowasser S
    Eur Respir J; 2015 Oct; 46(4):1113-30. PubMed ID: 26424523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palliative and end-of-life care for patients with idiopathic pulmonary fibrosis: challenges and dilemmas.
    Lewis D; Scullion J
    Int J Palliat Nurs; 2012 Jul; 18(7):331-7. PubMed ID: 22885965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Living with idiopathic pulmonary fibrosis: an in-depth qualitative survey of European patients.
    Schoenheit G; Becattelli I; Cohen AH
    Chron Respir Dis; 2011; 8(4):225-31. PubMed ID: 21856780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of idiopathic pulmonary fibrosis (IPF) and evidence-based guidelines.
    Sharif R
    Am J Manag Care; 2017 Jul; 23(11 Suppl):S176-S182. PubMed ID: 28978212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comorbidity in idiopathic pulmonary fibrosis - what can biomarkers tell us?
    Alfaro TM; Robalo Cordeiro C
    Ther Adv Respir Dis; 2020; 14():1753466620910092. PubMed ID: 32167024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health Care Costs at the End of Life for Patients with Idiopathic Pulmonary Fibrosis. Evaluation of a Pilot Multidisciplinary Collaborative Interstitial Lung Disease Clinic.
    Kalluri M; Lu-Song J; Younus S; Nabipoor M; Richman-Eisenstat J; Ohinmaa A; Bakal JA
    Ann Am Thorac Soc; 2020 Jun; 17(6):706-713. PubMed ID: 32197048
    [No Abstract]   [Full Text] [Related]  

  • 14. Idiopathic pulmonary fibrosis.
    Zolak JS; de Andrade JA
    Immunol Allergy Clin North Am; 2012 Nov; 32(4):473-85. PubMed ID: 23102062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clusters of comorbidities in idiopathic pulmonary fibrosis.
    Prior TS; Hoyer N; Hilberg O; Shaker SB; Davidsen JR; Rasmussen F; Bendstrup E
    Respir Med; 2021; 185():106490. PubMed ID: 34130097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-Related Quality of Life in Patients with Idiopathic Pulmonary Fibrosis.
    Yount SE; Beaumont JL; Chen SY; Kaiser K; Wortman K; Van Brunt DL; Swigris J; Cella D
    Lung; 2016 Apr; 194(2):227-34. PubMed ID: 26861885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comorbid Conditions in Idiopathic Pulmonary Fibrosis: Recognition and Management.
    Oldham JM; Collard HR
    Front Med (Lausanne); 2017; 4():123. PubMed ID: 28824912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and treatment of comorbidities in idiopathic pulmonary fibrosis and other fibrotic lung diseases.
    King C; Nathan SD
    Curr Opin Pulm Med; 2013 Sep; 19(5):466-73. PubMed ID: 23912191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive and practical approach to the management of idiopathic pulmonary fibrosis.
    Moran-Mendoza O; Colman R; Kalluri M; Cabalteja C; Harle I
    Expert Rev Respir Med; 2019 Jul; 13(7):601-614. PubMed ID: 31177864
    [No Abstract]   [Full Text] [Related]  

  • 20. Smoking-related emphysema is associated with idiopathic pulmonary fibrosis and rheumatoid lung.
    Antoniou KM; Walsh SL; Hansell DM; Rubens MR; Marten K; Tennant R; Hansel T; Desai SR; Siafakas NM; du Bois RM; Wells AU
    Respirology; 2013 Nov; 18(8):1191-6. PubMed ID: 23819865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.